معرفی
Professor Armando Santoro is a Full Professor at Humanitas University and serves as the Director of the Cancer Center at Humanitas Research Hospital in Milan, Italy. He is also the Director of the Department of Medical Oncology and Haematology and leads clinical research initiatives at the institute. His academic affiliations include long-standing teaching roles at the University of Milan and Pavia University.
His educational background includes:
- Medical Degree, University of Messina (1974)
- Certificate in Clinical and Experimental Cancerology, University of Paris (1976)
- Specialization in Clinical and Laboratory Hematology, University of Rome (1977)
- Specialization in Oncology, University of Genoa (1980)
- Postgraduate training at Memorial Sloan Kettering Cancer Center and Stanford University
Prof. Santoro’s research focuses on the development of novel cancer drugs and biological therapies, with particular interest in solid tumors and hematological malignancies. His work emphasizes personalized and integrated cancer care, including treatment for patients with comorbidities and cancer survivors. He has led and contributed to numerous high-impact clinical trials, especially in gastrointestinal cancers, breast cancer, and lymphomas.
His recent publications reflect a strong trend in targeted therapies, liquid biopsies, and precision oncology, with studies on KRAS inhibitors, circulating tumor DNA, and de-escalation of radiotherapy in lymphoma. These works are published in top-tier journals such as New England Journal of Medicine, Nature Medicine, and Blood.
His scientific awards include:
- Managing Doctor of the Year (2013)
- City of Siena S. Caterina d’Oro Award (2013)
- Serra Association Award for Scientific Research and Social Commitment (2009)
Prof. Santoro has been actively involved in national and international oncology networks, serving on committees such as the National Italian Committee on the Research Network in Oncology and the European Partnership for Action against Cancer. He has held leadership roles in professional organizations and contributes to public health policy through advisory positions in the Italian Ministry of Health. He is also a member of the Ethics Committee at Istituto Clinico Humanitas and coordinates regional oncology groups for esophageal, stomach, and liver cancers.
He leads a multidisciplinary research team at the Humanitas Cancer Center, which treats over 30,000 patients annually and is recognized for its integrated care model spanning emergency, outpatient, inpatient, and rehabilitative services.
